Trevor Clancy

Trevor Clancy

Company: NEC OncoImmunity

Job title: Chief Scientific Officer


An integrated AI approach for the prediction of Clinically Relevant Neoantigens 10:00 am

• Describing unique neoantigen discovery algorithms optimized for predicting neoantigen presentation to the tumor cell surface, in an improved manner • A machine learning ensemble approach is taken to variant calling, identifying accurately tumor specific variants • The AI platform is composed of numerous models integrated in deep learning layers to predict bone fide neoantigens…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.